{"schema":"hottub-news/story/v1","story":"st_hf3mdogwmaxv4iik4weq","title":"FDA Approves Expanded Use Of Lilly's Jaypirca For CLL/SLL","title_en":null,"outlets":3,"brief":null,"page":"https://hottub.news/stories/fda-approves-jaypirca-as-first-line-treatment-for-cll-and-sll-hf3mdogwma","count":3,"items":[{"id":"n_ontprppkrslw46rufirq","seq":1552146,"kind":"article","title":"FDA Approves Expanded Use Of Lilly's Jaypirca For CLL/SLL","url":"https://www.finanzen.ch/nachrichten/aktien/fda-approves-expanded-use-of-lillys-jaypirca-for-cll-sll-1036595289","published":"2026-10-03T15:22:11Z","seen":"2026-10-03T15:22:11Z","lang":"en","country":"CH","source":{"id":"finanzen.ch","name":"finanzen.ch","domain":"finanzen.ch"},"via":"gdelt-gkg-english","topics":["economy"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_hf3mdogwmaxv4iik4weq","category":"health","category_p":0.6000000238418579,"sentiment":"positive","tone":-0.14000000059604645,"political":0.07999999821186066},{"id":"n_owzfipchlkmzx4lpg5aa","seq":1559157,"kind":"article","title":"FDA Approves Expanded Use Of Lilly's Jaypirca For CLL/SLL","url":"https://www.rttnews.com/3696257/fda-approves-expanded-use-of-lilly-s-jaypirca-for-cll-sll.aspx","published":"2026-10-03T14:42:00Z","seen":"2026-10-03T16:23:19Z","lang":"en","source":{"id":"rttnews.com","name":"rttnews.com","domain":"rttnews.com","outlet":{"wikidata":"Q60748698","name":"RTTNews","type":"news_agency","designations":["news agency","news website"]}},"via":"gdelt-gkg-english","topics":["economy"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q1073913","name":"Lilly","type":"org"}],"story":"st_hf3mdogwmaxv4iik4weq","category":"health","category_p":0.6000000238418579,"sentiment":"positive","tone":-0.11999999731779099,"political":0.07999999821186066},{"id":"n_hf3mdogwmaxv4iik4weq","seq":1428770,"kind":"article","title":"FDA Approves Jaypirca as First-Line Treatment for CLL and SLL","url":"https://www.curetoday.com/view/fda-approves-jaypirca-as-first-line-treatment-for-cll-and-sll","published":"2026-10-02T19:51:00Z","seen":"2026-10-02T21:09:44Z","lang":"en","source":{"id":"curetoday.com","name":"curetoday.com","domain":"curetoday.com","outlet":{"wikidata":"Q5014714","name":"CURE","type":"magazine","designations":["magazine","website"]}},"via":"gdelt-gkg-english","topics":["education","economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q116622551","name":"pirtobrutinib","type":"other"},{"id":"Q1088156","name":"chronic lymphocytic leukemia","type":"other"},{"id":"Q107969614","name":"SLL","type":"other"}],"story":"st_hf3mdogwmaxv4iik4weq","category":"health","category_p":0.800000011920929,"sentiment":"positive","tone":-0.3400000035762787,"political":0.11999999731779099}]}